Marion Sessums, MD
Obstetrics & Gynecology · Hattiesburg, MSNPI 1972576460
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 65 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 17.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $372 and has fallen 77.6% since, to $83 in 2024. That places this record below the midpoint for obstetrics & gynecology clinicians in MS, where the typical reported total is $944.
Across 65 payments — averaging $17.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$197
- Mayne Pharma Commercial LLC$149
- Avion Pharmaceuticals$100
- Evofem Biosciences, Inc.$93
- Hologic Sales And Service, LLC$90
- Exeltis, USA Inc.$73
- plus $429 from 17 others
What the payments were for
- Food & beverage$1,131100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 10 | $197 |
| Mayne Pharma Commercial LLC | 7 | $149 |
| Avion Pharmaceuticals | 6 | $100 |
| Evofem Biosciences, Inc. | 6 | $93 |
| Hologic Sales And Service, LLC | 5 | $90 |
| Exeltis, USA Inc. | 3 | $73 |
| Johnson & Johnson | 2 | $45 |
| Teva Pharmaceuticals USA, Inc. | 3 | $42 |
| Pfizer | 3 | $41 |
| Bayer | 3 | $38 |
| Agile Therapeutics, Inc. | 2 | $34 |
| Merck | 2 | $33 |
| Sumitomo Pharma America, Inc. | 2 | $32 |
| Astellas Pharma US Inc | 2 | $31 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| BD | 1 | $17 |
| Novo Nordisk | 1 | $17 |
| Coopersurgical, Inc. | 1 | $17 |
| Amgen | 1 | $16 |
| Lupin Inc. | 1 | $13 |
| Coloplast | 1 | $12 |
| Minerva Surgical, Inc | 1 | $12 |
| Meditrina | 1 | $11 |
How this compares
$1,131 in reported general payments places this provider in the 50th percentile of 318 obstetrics & gynecology providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other obstetrics & gynecology in Hattiesburg
- Joseph WashburneHattiesburg$8K
- Lauren BetheaHattiesburg$5K
- Lauren BarryHattiesburg$5K
- Robert DesantisEllisville$212K
- Lori FultonJackson$102K
- Sheila BouldinJackson$56K
- Melissa BarnettTupelo$50K
- Ahmet BedestaniFlowood$41K
- Stacey KreherBay St. Louis$40K
- Joseph McGeheeTupelo$35K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.